Screener
West Pharmaceutical Services WST Return on invested capital
Return on invested capital at other companies
Other financials
Where this comes from
Calculated from West Pharmaceutical Services’s reported figures.
Based on trailing twelve months.
The source filing: West Pharmaceutical Services’s 10-Q, filed July 23, 2026. Open the filing →
- Filed
- Jul 23, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000105770-26-000099
FAQ
- What is West Pharmaceutical Services's return on invested capital?
- West Pharmaceutical Services (WST) reported return on invested capital of 19.3% in Q2 2026.
- How has West Pharmaceutical Services's return on invested capital changed year-over-year?
- West Pharmaceutical Services's return on invested capital increased by 7.9% year-over-year, from 17.8% to 19.3%.
- What is the long-term trend for West Pharmaceutical Services's return on invested capital?
- Over 5 years (2020 to 2025), West Pharmaceutical Services's return on invested capital has grown at a -4.1% compound annual growth rate (CAGR), from 22% to 17.9%.
- What does return on invested capital mean?
- Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.
Ask your AI about West Pharmaceutical Services's return on invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude